1 min read
Integra LifeSciences Prices $450 Million of Notes Due in 2033
The 9.5% senior secured notes are expected to close around Oct. 19, with proceeds supporting the refinancing of existing credit facilities.

Integra LifeSciences priced $450 million of 9.5% senior secured notes due in 2033, with the proceeds and borrowings under new credit facilities planned to refinance existing credit facilities.
The offering is expected to close around Oct. 19. The notes are part of a refinancing effort involving Integra’s existing credit facilities.